.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Teva
Novartis
US Army
Boehringer Ingelheim
Argus Health
McKesson
AstraZeneca
Cerilliant
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087463

« Back to Dashboard

NDA 087463 describes OXYCET, which is a drug marketed by Mallinckrodt and is included in one NDA. It is available from five suppliers. Additional details are available on the OXYCET profile page.

The generic ingredient in OXYCET is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Summary for 087463

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 087463

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 087463

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXYCET acetaminophen; oxycodone hydrochloride TABLET;ORAL 087463 ANDA Mallinckrodt, Inc. 0406-0512 0406-0512-01 100 TABLET in 1 BOTTLE (0406-0512-01)
OXYCET acetaminophen; oxycodone hydrochloride TABLET;ORAL 087463 ANDA Mallinckrodt, Inc. 0406-0512 0406-0512-62 100 TABLET in 1 BLISTER PACK (0406-0512-62)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;5MG
Approval Date:Dec 7, 1983TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Dow
Boehringer Ingelheim
US Army
Chinese Patent Office
Fuji
Cerilliant
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot